ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026
Single-Position Peptide Clustering for Peptidomics Reveals Novel Disease Biomarkers and Dysregulated Proteolytic Characteristics.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Single-Position Peptide Clustering for Peptidomics Reveals Novel Disease Biomarkers and Dysregulated Proteolytic Characteristics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Mass spectrometry-based peptidomics provides a comprehensive platform for mapping global proteolytic alterations and identifying disease biomarkers. However, existing analytical frameworks often lack the precision to capture disease-specific signatures. Here, a single-position peptide clustering strategy is introduced, leveraging the amino acid score (aa-score) method, and applying it to plasma peptidomics in β-thalassemia. By integrating grouped aa-scores with tailored visualization, a clear and interpretable profile of protein degradation is generated from otherwise redundant datasets. Importantly, the use of heavy-labeled peptides or reference samples in targeted quantitative peptidomics enabled, for the first time, the proposal of aa position-based peptide cluster biomarkers. Combined with proteomics and complementary analyses, this strategy revealed disease-specific peptide-protein-protease relationships. Furthermore, the robustness of the aa-score framework is demonstrated by applying an individualized algorithm based on reference samples in an independent cohort study, highlighting its capacity to address missing values and improve overall performance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.